• Are all Cochrane Reviews born equal? Statistical methods in Cochrane Reviews (could be improved) 2013 Québec City
• Are Australian Human Research Ethics Committees effectively promoting prospective trial registration? 2012 Auckland
• Are awaiting classification studies properly managed by Cochrane Reviews? 2019 Santiago
• Are claims made in advertisements of nutritional supplements in South African women’s magazines supported by research evidence? 2011 Madrid
• Are claims of interventional benefit in clinical trial abstract conclusions justifiable? A case report of pharmacological and complementary therapies for chronic asthma 2013 Québec City
• Are clinician-administered semi-structured interviews and lay-administered fully structured interviews equivalent gold standards for major depression? An individual patient data meta-analysis 2017 Cape Town [Global Evidence Summit]
• Are Cochrane plain language summaries plain? 2016 Seoul
• Are Cochrane Review Protocols available and post-protocol changes to methods documented? A study in HIV/AIDS and ophthalmology 2014 Hyderabad
• Are Cochrane reviews for end users of healthcare services? The results of an international survey 2009 Singapore
• Are Cochrane reviews of diagnostic test accuracy informing clinical guidelines? 2018 Edinburgh
• Are Cochrane Reviews Updated Regularly or Not? 2002 Stavanger
• Are Cochrane systematic reviews being used in national clinical practice guidelines for chronic kidney disease? 2008 Freiburg
• Are computerized clinical decision support systems effective at improving the process of care and patient outcomes, and what makes an effective system? A decision-maker-researcher partnership systematic review 2011 Madrid
• Are conference abstracts of systematic reviews reliable and well-reported? A case study of five consecutive World Congresses of Pain 2019 Santiago
• Are criteria to evaluate the appropriateness of performing colonoscopy evidence based? 1997 Amsterdam
• Are harms reported in abstracts of trial results from conference proceedings? 2006 Dublin
• Are health authority policy and commissioning decisions evidence-based? 1998 Baltimore
• Are Health Technology Assessment (HTA) funded trials using systematic reviews to inform their design? A retrospective cohort 2015 Vienna
• Are individual/small group interventions in math more effective than class/school level interventions? A meta-analysis of What Works Clearinghouse reviews 2017 Cape Town [Global Evidence Summit]
• Are men difficult to find? Identifying sex-specific studies in MEDLINE and Embase 2013 Québec City
• Are online learning resources effective to build capacity for evidence-informed decision making? 2015 Vienna
• Are overviews of (systematic) reviews really of good quality and transparent information? 2011 Madrid
• Are patient-reported outcomes evaluated in randomized controlled trials and meta-analyses regarding reconstruction methods after distal gastrectomy? 2023 London
• Are Polish physicians familiar with the Cochrane Collaboration and the Cochrane Library? 2015 Vienna
• Are predictions from test accuracy meta-analyses valid in practice? 2015 Vienna
• Are public health strategies relevant to non-communicable disease in China covered in the Cochrane Library? 2014 Hyderabad
• Are RCTs addressing evidence based healthcare education following evidence based research approach? 2024 Prague [Global Evidence Summit]
• Are reporting and methodological quality of systematic reviews from China lower than those from USA? A meta-epidemiological study 2016 Seoul
• Are results from clinical study registers considered in recent interventional Cochrane Reviews? A systematic review 2018 Edinburgh
• Are retracted studies affecting our reviews? 2018 Edinburgh
• Are routinely collected data studies reliable surrogates when there are no randomized trials? A meta-epidemiological study 2015 Vienna
• Are school-based mindfulness interventions effective? A Campbell systematic review and meta-analysis 2017 Cape Town [Global Evidence Summit]
• Are supplementary feeding programmes to improve the health of disadvantaged young children effective? For whom and under what circumstances? 2015 Vienna
• Are systematic reviews in danger of amplifying the unimportant questions? The case of dermatology 1999 Rome
• Are systematic reviews original research? - survey of editors of core clinical journals 2010 Keystone
• Are test treat trials as rare as suspected? A capture-recapture estimate of numbers published 2010 Keystone
• Are the estimates of blood pressure (BP) lowering effect the same in parallel and cross-over trials? 2015 Vienna
• Are the integrative practices recently incorporated into the Brazilian public healthcare system supported by evidence from Cochrane Reviews? 2019 Santiago
• Are the search and data extraction procedures similar between Cochrane Reviews and systematic reviews from other high impact factor journals? 2018 Edinburgh
• Are the searches of network meta-analysis comprehensive or well-reported? 2011 Madrid
• Are there differences in results between Bayesian and Frequentist network meta-analyses 2017 Cape Town [Global Evidence Summit]
• Are there discipline-specific quality measures? A systematic review of meta-epidemiological studies 2011 Madrid
• Are there missing randomized trials in Cochrane systematic reviews and what is their impact on the results?: A methodological study 2023 London
• Are they doing what it says on the packet? Towards an implementation fidelity index for use in systematic reviews 2005 Melbourne
• Are trial size and reported methodological quality associated with treatment effects? Observational study of 523 randomised trials 2004 Ottawa
• Are unpublished data searched for and included in systematic reviews? A survey of 348 reviews of adverse effects 2016 Seoul
• Are volunteers authoring Cochrane reviews? A brief investigation. 2012 Auckland
• Are we evaluating methodological quality in the same way? Comparison of tools used in general health research and physical therapy with the 'Risk of bias' tool 2011 Madrid
• Are we listening to QUOROM (Quality of Reporting of Meta-analyses)? An evaluation of journal-published oral health systematic reviews 2006 Dublin
• Are we managing the influx of living systematic reviews? "Behemoths" and "side quests" 2024 Prague [Global Evidence Summit]
• Are we overestimating harm when high numbers of placebo patients are switched to active therapy as part of an adaptive trial design? A meta-epidemiological study 2015 Vienna
• Are you listening? Podcasts from The Cochrane Library; a review 2010 Keystone
• Are you listening? Podcasts from The Cochrane Library: a review of 2008 2009 Singapore
• Are you searching the right database? An example from mental health 1998 Baltimore
• Area of prediction ellipse in diagnostic test accuracy reviews: Implementation in R and application to different review scenarios 2017 Cape Town [Global Evidence Summit]
• ARIA (ADAPTED RESOURCE AND IMPLEMENTATION APPLICATION) DISEASE-BASED GUIDELINE DEVELOPMENT APPROACH: INTEGRATING GLOBAL REPRESENTATION WITH EVIDENCE- AND CONSENSUS-BASED METHODS 2024 Prague [Global Evidence Summit]
• Arm-based versus contrast-based methods for network meta-analyses: radical differences or misunderstood nuances? 2016 Seoul
• Arriving at a bottom line for evidence quality: precision of the estimate 2007 Sao Paulo
• Artemesinin-based combination therapy for uncomplicated Malaria management among children under-5 in Cameroon: A best-practice implementation project 2017 Cape Town [Global Evidence Summit]
• Artemisinin-based combination therapies for malaria: a systematic review and network meta-analysis 2020 Abstracts
• Arthroplasty registries as a source of information for decision making: a comprehensive overview 2015 Vienna
• Artificial intelligence (AI) in drug discovery process: an overview 2024 Prague [Global Evidence Summit]
• Artificial intelligence in evidence production: critical reflections and lessons learned 2024 Prague [Global Evidence Summit]
• Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta-analysis 2024 Prague [Global Evidence Summit]
• Artificial intelligence tools for screening references in systematic reviews. Preliminary Results of Scoping Review 2024 Prague [Global Evidence Summit]
• Artificial intelligence-generated plain-language summaries from Systematic Reviews for improving general public healthcare participation using the best evidence 2024 Prague [Global Evidence Summit]
• Artificially defined transformation methods for obtaining dose points in dose-response meta-analysis should be more standardized: a cross-section study. 2020 Abstracts
• Ask Suicide-Screening Questionnaire (ASQ): Rapid Suicide Risk Screening for Hospitalized Patients 2024 Prague [Global Evidence Summit]
• Ask the author? Does it make a difference to quality assessment? 2005 Melbourne
• Aspirin Chemoprophylaxis: Weighing the benefits and harms for patients at different levels Of risk for cardiovascular disease. 2000 Cape Town
• Assessing adverse effects of interventions in Cochrane reviews: what types of study designs are used? 2014 Hyderabad
• Assessing and Addressing the Perceived Barriers to Evidence-Based Stroke Rehabilitation 1999 Rome
• Assessing and adjusting for outcome reporting bias in systematic reviews 2015 Vienna
• Assessing and building capacity for clinical guideline development in Malawi, South Africa, and Nigeria 2024 Prague [Global Evidence Summit]
• Assessing and improving quality of reporting the estimated effect size and its precision in randomized controlled trials 2009 Singapore
• Assessing and validating search strategies: When is a study truly identified? 2017 Cape Town [Global Evidence Summit]
• Assessing applicability, scaling up and equity issues in Cochrane reviews: A worked example from a review of lay health worker interventions in primary and community health care for chronic conditions 2011 Madrid
• Assessing attitudes towards dietary fats in five countries: development and validation of Fat-related Attitude Scale (FATTS) 2024 Prague [Global Evidence Summit]
• Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool 2013 Québec City
• Assessing bias due to confounding in a Cochrane Systematic Review that includes non-randomised studies of an intervention (NRSI) 2015 Vienna
• Assessing bias due to confounding in a Cochrane systematic review which includes non-randomised studies of an intervention (NRSI) 2016 Seoul
• Assessing bias due to missing data in a systematic review that includes non-randomised studies (NRS) 2014 Hyderabad
• Assessing bias in osteoarthritis trials included in Cochrane reviews 2014 Hyderabad
• Assessing bias in selection of participants into studies in a Cochrane Review that includes non-randomised studies of an intervention (NRSI) 2015 Vienna
• Assessing bias in selection of participants into the study in a Cochrane Systematic Review that includes non-randomised studies of an intervention (NRSI) 2016 Seoul
• Assessing characteristics and outcomes of interventions designed to mitigate the effects of adverse childhood experiences: A Scoping review 2024 Prague [Global Evidence Summit]
• Assessing conceptual richness in a meta-ethnography: an example from a qualitative evidence synthesis on factors influencing acceptance of childhood vaccination 2020 Abstracts
• Assessing confidence in qualitative evidence used in guidelines: Benefits and challenges when applying GRADE-CERQual 2017 Cape Town [Global Evidence Summit]
• Assessing dementia care gaps to guide clinical guidance scoping and other implementation efforts—the Singapore experience 2024 Prague [Global Evidence Summit]
• Assessing equity, applicability and scaling up issues in Cochrane reviews: a worked example from a review of lay health worker interventions in primary and community health care 2007 Sao Paulo
• Assessing ethics and equity issues in systematic reviews and primary studies of nutrition interventions 2013 Québec City
• Assessing Financial Conflicts of Interest in Published Research Using a Large Language Model: A Proof of Concept Study 2024 Prague [Global Evidence Summit]
• Assessing generalizability of findings in systematic reviews of public health interventions: methods of the US Community Preventive Services Task Force 2013 Québec City
• Assessing GPT-3.5 Turbo’s performance in primary screening across diverse types of systematic literature reviews 2024 Prague [Global Evidence Summit]
• Assessing healthcare interventions along the complex-simple continuum 2006 Dublin
• Assessing healthcare interventions along the complex-simple continuum: a proposal 2006 Dublin
• Assessing heterogeneity in meta-analysis: what Q, I², Tau², and prediction intervals do and do not tell us 2024 Prague [Global Evidence Summit]
• Assessing how information is packaged in rapid reviews for policymakers and other stakeholders: a cross-sectional study 2019 Santiago
• Assessing how much certainty to place in findings from qualitative evidence syntheses: the CerQual approach 2013 Québec City
• Assessing how much confidence to place in findings from qualitative evidence syntheses: a new version of the CERQual tool 2014 Hyderabad
• Assessing how much confidence to place in findings from qualitative evidence syntheses: a new version of the GRADE-CERQual approach 2016 Seoul
• Assessing how much confidence to place in findings from qualitative evidence syntheses: a new version of the GRADE-CERQual tool 2015 Vienna
• Assessing how well interventions for migrant population have addressed inequity: a two-stage systematic review 2018 Edinburgh
• Assessing implementation in complex interventions: tips, strategies and examples 2015 Vienna
• Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis 2018 Edinburgh
• Assessing Leg Ulcer Prevalence Studies: Conceptual, Methodological and Practical Issues 1999 Rome
• Assessing methodological quality in a large research literature: the case of distance education comparison studies 2004 Ottawa
• Assessing Methodological Quality in Cohort Studies: A Comparison of NOS and ROBINS-I 2024 Prague [Global Evidence Summit]
• Assessing methodological quality of primary studies and applying results in the cochrane reviews. An evaluation of the drugs and alcohol group s reviews. 2004 Ottawa
• Assessing publication bias in systematic reviews andmeta-analyses in the context of small n trials: application of a capture-recapture method 2013 Québec City
• Assessing quality in systematic reviews of the effective­ness of health promotion and public health: areas of consensus and dissension 2009 Singapore
• Assessing risk of bias (RoB) in randomized trials: RoB 2.0 2018 Edinburgh
• Assessing risk of bias in comparative diagnostic accuracy studies using QUADAS-C 2023 London
• Assessing risk of bias in included studies: the recommended tool for Cochrane reviews 2008 Freiburg
• Assessing risk of bias in non-randomised studies and incorporating GRADE: Initial experience with a new Cochrane 'Risk of bias' tool under development 2011 Madrid
• Assessing risk of bias in non-randomized studies of interventions (1): introduction to the ROBINS-I tool 2019 Santiago
• Assessing risk of bias in non-randomized studies of interventions 2: an online tool to facilitate risk of bias assessments using the ROBINS-I tool 2019 Santiago
• Assessing risk of bias in non-randomized studies of interventions: introduction to the ROBINS-I tool 2023 London
• Assessing risk of bias in nonrandomized studies of interventions: introduction to the ROBINS-I tool 2024 Prague [Global Evidence Summit]
• Assessing risk of bias in randomised studies: RoB 2.0 2017 Cape Town [Global Evidence Summit]
• Assessing risk of bias in randomized trials: RoB 2 2019 Santiago
• Assessing risk of bias: comparison of the PEDro scale with Cochrane’s ‘Risk of bias’ tool 2008 Freiburg
• Assessing risk of lead-time bias in studies of overdiagnosis 2017 Cape Town [Global Evidence Summit]
• Assessing risk of performance and detection bias in Cochrane reviews as a single domain is less accurate compared to assessment of two separate domains 2020 Abstracts
• Assessing spin bias in abstracts of systematic reviews from Revista médica de Chile between 2017-2021 2023 London
• Assessing success of guideline implementation: development of a generalized tool facilitating cross-comparison and targeted improvement 2024 Prague [Global Evidence Summit]
• Assessing the Accuracy, Reliability and Quality of Online Health Information of Treatment for Patients With COVID-19 2020 Abstracts
• Assessing the availability, scope, and quality of stroke rehabilitation guidelines in LMICs - a systematic review of quality and scope 2024 Prague [Global Evidence Summit]
• Assessing the body of evidence and grading recommendations in evidence-based clinical practice guidelines 2005 Melbourne
• Assessing the certainty across a body of evidence for comparative test accuracy 2020 Abstracts
• Assessing the certainty of evidence in overviews of reviews: current practice and expert perspectives 2018 Edinburgh
• Assessing the certainty of evidence in studies about peoples’ values, utilities, or the importance of outcomes 2024 Prague [Global Evidence Summit]
• Assessing the certainty of the evidence from network-meta analysis using the GRADE approach 2023 London
• Assessing the certainty of the evidence from network-meta analysis using the GRADE approach 2019 Santiago
• Assessing the certainty of the evidence from network-meta analysis using the GRADE approach 2017 Cape Town [Global Evidence Summit]
• Assessing the certainty of the evidence in network meta-analysis: GRADE approach 2016 Seoul
• Assessing the completeness and comparability of outcomes in systematic reviews addressing food availability 2018 Edinburgh
• Assessing the completeness of systematic reviews via the 'related articles' function and/or a simple structured Boolean search in PubMed,-,a pilot study 2011 Madrid
• Assessing the Current Landscape of Health Technology Assessment Knowledge and Skills Among Clinicians in Croatia 2024 Prague [Global Evidence Summit]
• Assessing the effect of adjusting for funnel plot asymmetry in networks of interventions 2010 Keystone
• Assessing the Effectiveness and Safety of Deep Brain Stimulation in Severe and Refractory Obsessive-Compulsive Disorder: A Living Systematic Review 2024 Prague [Global Evidence Summit]
• Assessing the effectiveness of artificial intelligence tools in automating systematic reviews for cancer research: a systematic review 2024 Prague [Global Evidence Summit]
• Assessing the effects of diagnostic tests on patient outcomes: how reliable, informative and practical are randomised controlled trials? 2008 Freiburg
• Assessing the efficacy of anti-depressant treatment: methodological considerations for meta-analysis 1996 Adelaide
• Assessing the feasibility of network meta-analyses comparing pharmacological and non-pharmacological interventions for psychiatric disorders 2018 Edinburgh
• Assessing the impact of bibliographical support on the quality of medical care in patients admitted to an internal medicine service 2015 Vienna
• Assessing the impact of climate change on Eastern equine encephalitis virus in Canada. 2020 Abstracts
• Assessing the impact of diverse definitions of major adverse cardiac events on coronary stent study outcomes 2024 Prague [Global Evidence Summit]
• Assessing the impact of information retrieval in postgraduate medical education 2004 Ottawa
• Assessing the impact of missing participant data for continuous outcomes in systematic reviews on risk of bias 2012 Auckland
• Assessing the methodological and reporting quality of clinical Systematic reviews and meta-analyses published in the Leading Sports medicine Journals 2020 Abstracts
• Assessing the methodological quality of systematic review: the AMSTAR II-DTA extension 2019 Santiago
• Assessing the methodological strengths and limitations of qualitative evidence: What are the key criteria? 2017 Cape Town [Global Evidence Summit]
• Assessing the methodological strengths and limitations of qualitative evidence: what are the key criteria? 2018 Edinburgh
• Assessing the number, characteristics and quality of randomized controlled trials conducted in Japan 2012 Auckland
• Assessing the optimal presentation of how patients value health outcomes (values and preferences): A qualitative user testing 2017 Cape Town [Global Evidence Summit]
• Assessing the prognostic power of prediction rules: A Users’ Guide to the medical literature 2017 Cape Town [Global Evidence Summit]
• Assessing the quality of a body of evidence: experiences with the GRADE approach 2009 Singapore
• Assessing the quality of diagnostic studies that use psychometric instruments: applying QUADAS in a novel area 2008 Freiburg
• Assessing the quality of economic studies of health care-searching for an ideal instrument 1998 Baltimore
• ASSESSING THE QUALITY OF EVIDENCE IN NON-COCHRANE SYSTEMATIC REVIEWS 2024 Prague [Global Evidence Summit]
• Assessing the quality of information recorded on trial registries 2005 Melbourne
• Assessing the quality of non-randomised comparative studies: Our experience of using the Cochrane Collaboration’s risk of bias tool} 2011 Madrid
• Assessing the Quality of Primary Studies: Empirical Study of Meta-Analyses Published in Leading Journals 1999 Rome
• Assessing the quality of randomized controlled trials evaluating nonpharmacological treatments: a CheckList to Evaluate A Report of NonPharmacological Trial (CLEAR NPT) 2005 Melbourne
• Assessing the Quality of Reporting Meta-analyses of Randomized Controlled Trials 1999 Rome
• Assessing the Quality of Reports of Systematic Reviews and Meta-analyses: A Systematic Review of Checklists and Scales 1999 Rome
• Assessing the quality of surveillance studies 2014 Hyderabad
• Assessing the quality of the evidence for preterm labor tocolysis trials 2010 Keystone
• Assessing the richness and thickness of data in primary qualitative research included in qualitative evidence synthesis 2024 Prague [Global Evidence Summit]
• Assessing the risk of bias associated with missing participant outcome data: applying decision thresholds for binary data 2016 Seoul
• Assessing the risk of bias associated with missing participants in randomized controlled trials: a systematic review and meta-analysis in autologous cell therapy for peripheral arterial disease 2018 Edinburgh
• Assessing the Risk of Bias in Randomised Controlled Trials with Large Language Models: A Feasibility Study 2024 Prague [Global Evidence Summit]
• Assessing the Risk of Bias in Randomized Controlled Trials using RoB2 by Large Language Models: A Feasibility Study 2024 Prague [Global Evidence Summit]
• Assessing the risk of confounding and selection bias in a systematic review that includes non-randomized studies (NRS) 2014 Hyderabad
• Assessing the risk of selection bias in a systematic review which includes non-randomised studies (NRS) 2013 Québec City
• Assessing the risk of within-study selective reporting in a systematic review which includes non-randomised studies (NRS) 2013 Québec City
• Assessing the success of blinding in randomized controlled trials 2005 Melbourne
• Assessing the usability of ACROBAT-NRSI for studies of exposure and intervention in environmental health research 2015 Vienna
• Assessing the validity of abbreviated literature searches in rapid reviews 2017 Cape Town [Global Evidence Summit]
• Assessing the validity of an ultra-rapid review strategy: four case studies from oncology and public health 2018 Edinburgh
• Assessing transparency and reproducibility practices in dental randomized controlled trials 2024 Prague [Global Evidence Summit]
• Assessing trial quality by a short and a detailed list 1995 Oslo
• Assessment and management of burns pain at the Komfo Anokye Teaching Hospital: A best-practice Implementation Project 2017 Cape Town [Global Evidence Summit]
• Assessment of attitudes towards participation, willingness to participate, and competence to participate in Randomized Controlled Trials: a cross-sectional qualitative and quantitative survey of psychiatric patients and key family members 2014 Hyderabad
• ASSESSMENT OF CERTAINTY OF EVIDENCE IN SYSTEMATIC REVIEWS PUBLISHED IN BRAZILIAN OTORHINOLARYNGOLOGY JOURNALS. 2024 Prague [Global Evidence Summit]
• Assessment of dialysis technology:- a Cochrane systematic review comparing bicarbonate with acetate haemodialysis in ESRD 1997 Amsterdam
• Assessment of health equity considerations in WHO guidelines from 2014-2019: A cross-sectional survey 2020 Abstracts
• Assessment of hospital capacities in patient safety in the Philippines 2011 Madrid
• Assessment of knowledge, skills and attitude of undergraduate students on evidence-based medicine 2014 Hyderabad
• Assessment of Language Bias and Indexing Bias Among Chinese-Sponsored Randomized Controlled Trials 2020 Abstracts
• Assessment of methodological limitations in qualitative evidence synthesis - pilot test of a new tool 2019 Santiago
• Assessment of methodological quality of adaptive clinical trials 2014 Hyderabad
• Assessment of methodological quality of clinimetric reviews: a systematic review 2006 Dublin
• Assessment of methodological quality of systematic reviews of China health policy 2013 Québec City
• Assessment of methodological quality of systematic reviews published in the Cochrane Library about physical activity for chronic noncommunicable diseases 2012 Auckland
• Assessment of methods to adjust for publication bias through a comprehensive simulation study 2008 Freiburg
• Assessment of non-pharmacological interventions to manage geriatric conditions using GRADE 2015 Vienna
• Assessment of publication bias based on clinical trial registrations 2017 Cape Town [Global Evidence Summit]
• ASSESSMENT OF PUBLICATION BIAS IN BREAST CANCER SYSTEMATIC REVIEWS 2020 Abstracts
• Assessment of publication time and Review process in Campbell Systematic Reviews 2024 Prague [Global Evidence Summit]
• Assessment of Reporting Guidelines and Trial Registration Requirements in Nursing Journals: A Decade-Long Review 2023 London
• Assessment of reporting of evidence-based healthcare (EBHC) e-learning interventions in included studies of a Campbell systematic review 2017 Cape Town [Global Evidence Summit]
• Assessment of reporting of stroke clinical practice guidelines in low- and medium-income countries using the RIGHT checklist: a scoping review 2024 Prague [Global Evidence Summit]
• Assessment of reporting quality in infertility journals 2014 Hyderabad
• Assessment of research quality in major infertility journals 2012 Auckland
• Assessment of risk of bias due to blinding for objective and subjective outcomes: an exploratory study of Cochrane Reviews 2013 Québec City
• Assessment of risk of bias in comparative diagnostic accuracy systematic reviews: an overview of reviews 2019 Santiago
• Assessment of risk of bias in prognostic studies 2010 Keystone
• Assessment of Russian clinical practice guidelines with the AGREE II instrument 2017 Cape Town [Global Evidence Summit]
• Assessment of Soil-Transmitted Helminths Among School-Aged Children (5-18 Years) in Low- to Middle-Income Nations: A Systematic Review and Meta-Analysis 2024 Prague [Global Evidence Summit]
• Assessment of the Cochrane ‘Risk of bias’ tool: a pilot study 2008 Freiburg
• Assessment of the completeness of reporting of methods in overviews of systematic reviews 2018 Edinburgh
• Assessment of the evidence for diagnostic tests and strategies: a systematic review of available tools 2013 Québec City
• Assessment of the exclusion criteria among randomized controlled trials (RCTs) in dentistry: preliminary results of a pilot study 2019 Santiago
• Assessment of the GRADE domain “publication bias” in recent Cochrane reviews: a cross-sectional study 2024 Prague [Global Evidence Summit]
• Assessment of the methodological quality of reporting of randomized trials in Iranian dental journals 2008 Freiburg
• Assessment of the methodological quality of reporting of randomized trials in Iranian healthcare journals 2006 Dublin
• Assessment of the methodology approach of systematic reviews of the literature in speech therapy degree students 2019 Santiago
• Assessment of the quality of clinical trials registries 2013 Québec City
• Assessment of the quality of recommendations in high-quality methodological clinical practice guidelines for mental health care and epilepsy in pregnancy 2024 Prague [Global Evidence Summit]
• Assessment of the quality of reporting for treatment components in Cochrane Reviews of acupuncture 2013 Québec City
• Assessment of the quality of reporting in randomized controlled trials of acupuncture in the Korean literature using the CONSORT and STRICTA statements 2013 Québec City
• Assessment of the reporting quality of clinical practice guidelines using CheckUP list/tool 2017 Cape Town [Global Evidence Summit]
• Assessment of the reporting quality of Guidelines on Acupuncture and Moxibustion by using RIGHT Statement 2017 Cape Town [Global Evidence Summit]
• Assessment of the risk of bias in randomized controlled trials in otorhinolaryngology 2016 Seoul
• Assessment of the validity of a resources-saving selection procedure for non-English studies in systematic reviews 2008 Freiburg
• Assessment of trial risk of bias among Cochrane reviews: A cross-sectional analysis 2011 Madrid
• Assessment of trial similarity and evidence consistency for indirect comparisons: preliminary results 2010 Keystone
• Assessment of trustworthiness has a significant impact on conclusions of Cochrane reviews 2023 London
• Assessment of use and scope for use of IPD in a random sample of 100 reviews from the Cochrane Pregnancy and Childbirth group 2015 Vienna
• Assigning GRADE levels in an overview of reviews using general principles identified from current GRADE guidelines. 2024 Prague [Global Evidence Summit]
• Assisting Recommendations Formulation of Practice Guideline with Large Language Models: A Feasibility Study 2024 Prague [Global Evidence Summit]
• AssociALi - Cochrane Associate Center: 18 months of activities dedicated to spreading a culture of EBM in Italy. 2023 London
• Associated factors with abdominal aortic aneurysm: a systematic review of literature 1998 Baltimore
• Association between alcohol intake, mild cognitive impairment and progression to dementia: a dose-response meta-analysis 2020 Abstracts
• Association between cigarette smoking prevalence and income level: a systematic review and meta-analysis 2016 Seoul
• Association between industry affiliation and position on rosiglitazone and cardiovascular risk: a cross sectional systematic review 2010 Keystone
• Association between insomnia drugs and adverse events in adults: a systematic review and network meta-analysis 2024 Prague [Global Evidence Summit]
• Association between perioperative hypothermia and the incidence of blood coagulation disorders: a systematic review 2024 Prague [Global Evidence Summit]
• Association between personal financial conflicts of interest and recommendation of medical interventions: systematic review 2013 Québec City
• Association between risk of bias and the effects of interventions on mortality in randomized controlled trials in critical care medicine 2011 Madrid
• Association between the burden of behavioural risk factors and the number of primary studies included in Cochrane Systematic reviews 2020 Abstracts
• Association of healthy lifestyle behaviors with incident irritable bowel syndrome: a large population-based prospective cohort study 2024 Prague [Global Evidence Summit]
• Association of previous stillbirth with subsequent perinatal outcomes: A systematic review and meta-analysis of cohort studies 2024 Prague [Global Evidence Summit]
• Associations of hand-washing frequency with the incidence of illness: a systematic review and meta-analysis 2020 Abstracts
• Asthma self-management educational interventions versus usual care for adults: a systematic review and meta-analysis of 22 controlled trials with 3304 patients 2004 Ottawa
• At the beginning of a public health emergency what’s the utility of a conducting a systematic review? 2023 London
• At what point in the life cycle of technologies are HTA reports requested? An analysis of 130 HTA reports in Argentina 2016 Seoul
• Attack of zombie reviews? How can journals help reduce research waste—an editors’ perspective 2024 Prague [Global Evidence Summit]
• Attitude, expectation and needs of Cochrane knowledge translation volunteers in China 2019 Santiago
• Attitudes and implementation of shared decision making: the practicalities of consumer involvement among patients with chronic diseases 2008 Freiburg
• Attitudes of guideline developers regarding machine learning and crowd sourcing for health-evidence synthesis 2017 Cape Town [Global Evidence Summit]
• Attitudes towards evidence based medicine among medical students of Universidad Nacional del Sur Medical School of Argentina 2013 Québec City
• Attributes of non-randomized studies associated with bias 2011 Madrid
• Attribution of credit in updated Cochrane reviews 2023 London
• Attribution of multiple literature databases in systematic reviews for public health guideline development 2016 Seoul
• Attrition bias, the use of intention-to-treat and magnitude of treatment effects in randomized controlled trials: a meta-epidemiological study 2019 Santiago
• Atypical patient and public involvement (PPI): how to expand PPI into highly technical research 2024 Prague [Global Evidence Summit]
• Audio-visual resources for key evidence-based medicine terms and concepts: findings from an e-learning project 2018 Edinburgh
• Audio-visual Resources of Testing Treatments (AVRTT) 2017 Cape Town [Global Evidence Summit]
• Audit of the use of clinical trial registries in Cochrane Intervention Reviews – preliminary results 2017 Cape Town [Global Evidence Summit]
• Augmented reality in surgery: an overview of systematic reviews 2024 Prague [Global Evidence Summit]
• Australian Aboriginal children:- the randomised controlled trial and special populations 1996 Adelaide
• Australian Living Guidelines for Management and Care of Patients with COVID-19 Infection 2020 Abstracts
• Australian New Zealand Clinical Trials Registry (ANZCTR) user survey results from 2009 and 2015 2015 Vienna
• Australian Physicians and EBM: Where are we now and Where to from here? 2000 Cape Town
• Australian recommendations on the use of glucocorticoids in people with rheumatoid arthritis 2024 Prague [Global Evidence Summit]
• Authenticity investigation and quality assessment of claimed randomized controlled trials on upper respiratory infection 2006 Dublin
• Author affiliation influences the presentation of benefits and harms of mammography screening in scientific articles 2006 Dublin
• Author instructions of haematology and oncology journals: A cross-sectional and longitudinal study 2017 Cape Town [Global Evidence Summit]
• Author self-classification of conference proceeding abstracts 2004 Ottawa
• Author-led webinars as an education strategy for communicating systematic review evidence to a public-health audience 2018 Edinburgh
• Authoring and editing reviews through the new Cochrane Information Management System: an introductory workshop for review authors and editors 2005 Melbourne
• Authors need guidance on creating clinical pathways in Cochrane diagnostic test accuracy systematic reviews 2015 Vienna
• Authorship diversity among first authors of original investigation articles published in Revista Medica de Chile between 2017-2021 2023 London
• Authorship diversity among systematic reviews in eyes and vision 2019 Santiago
• Authorship in reports of clinical practice guidelines: a systematic cross-sectional analysis 2018 Edinburgh
• Authorship trends in Cochrane reviews, 1996-2018 2019 Santiago
• Automated assessing completeness and accuracy of reporting randomized clinical trials: based on large language models 2024 Prague [Global Evidence Summit]
• Automated checking for human errors in meta-analyses of diagnostic test accuracy 2019 Santiago
• Automated citation searching in systematic review production: a simulation study 2024 Prague [Global Evidence Summit]
• Automated extraction of adverse drug reactions from Biomedical literature and FDA drug labels using machine learning 2020 Abstracts
• Automated extraction of adverse drug reactions from biomedical literature and Food and Drug Administration (FDA) drug labels using machine learning 2019 Santiago
• Automated Indexing of Publication Types and Study Designs in Biomedical Literature 2024 Prague [Global Evidence Summit]
• Automated translation of abstracts using a free internet software package 2000 Cape Town
• Automatic generation of comprehensive trial registers for specific health conditions 2019 Santiago
• Automatic information retrieval: citation tracking, deduplication and full-text fetching 2014 Hyderabad
• Automatic search strategy reformulation interface for systematic reviews 2019 Santiago
• Automating RCT identification can identify more than 99% of RCTs included in Cochrane reviews and could reduce manual screening by 77% 2017 Cape Town [Global Evidence Summit]
• Automating risk-of-bias assessment with generative AI 2024 Prague [Global Evidence Summit]
• Automating Screening of Studies for Systematic Reviews Using a Large Language Model 2024 Prague [Global Evidence Summit]
• Automation in Systematic Reviews: A Cross-Sectional Metaresearch Survey 2024 Prague [Global Evidence Summit]
• Automation of scoping reviews: towards the efficiency of systematic reviews 2023 London
• Availability of eye health–related evidence relevant to low- and middle-income countries: using an evidence gap map approach 2024 Prague [Global Evidence Summit]
• Availability of large-scale evidence on specific harms from systematic reviews of randomised trials 2004 Ottawa
• Avoiding informal recommendations: a framework for identifying and managing guideline statements 2020 Abstracts
• Awareness and perception of dissemination bias in qualitative research: an exploratory study 2015 Vienna
• Awareness and use of evidence-based medicine databases and The Cochrane Library among physicians in Croatia 2010 Keystone
• Awareness and use of the Cochrane Library in internal medicine 2013 Québec City
• Awareness of The Cochrane Collaboration and The Cochrane Library in India 2009 Singapore
• Background section at Cochrane reviews: is it supported by systematic reviews? 2018 Edinburgh
• Bad examples of Interference In the conduct and publication of clinical research 1999 Rome
• BADERI: an Internet-based platform to co-ordinate handsearching activities. Implementation and early results 2017 Cape Town [Global Evidence Summit]
• Balancing efficiency with methodological rigor when synthesizing evidence to inform guideline recommendations during a pandemic 2024 Prague [Global Evidence Summit]
• Balancing risks, harms and benefits in guideline development for pain management 2017 Cape Town [Global Evidence Summit]
• Banning smoking in vehicles with children: Lessons from a realist review 2010 Keystone
• Barriers and concerns in patient perceptions of shared decision making in China 2008 Freiburg
• Barriers and enablers for the implementation of clinical practice guidelines in Latin America: A scoping review 2024 Prague [Global Evidence Summit]
• Barriers and Enablers to Access Diabetic Eye Care: Systematic Review 2024 Prague [Global Evidence Summit]
• Barriers and Facilitators in Application of the Living Guideline Framework in Oncology–A Mixed Methods Study 2024 Prague [Global Evidence Summit]
• Barriers and facilitators in clinical pathway implementation: A literature review 2017 Cape Town [Global Evidence Summit]
• Barriers and facilitators in the implementation of interventions to prevent publication bias 2013 Québec City
• Barriers and facilitators to completing a Cochrane Review: a survey of authors in the African region 2013 Québec City
• Barriers and facilitators to handsearching: experience of the Brazilian Cochrane Centre 2014 Hyderabad
• Barriers and facilitators to implementation in dementia care: Findings from a qualitative evidence synthesis 2017 Cape Town [Global Evidence Summit]
• Barriers and facilitators to implementing evidence in African healthcare: A content analysis 2017 Cape Town [Global Evidence Summit]
• Barriers and facilitators to postnatal care services utilisation in low- and middle-income countries: A Cochrane/EPOC systematic review 2017 Cape Town [Global Evidence Summit]
• Barriers and facilitators to sharing of individual patient data: a randomised controlled trial 2018 Edinburgh
• Barriers and methods to improve the use of Cochrane systematic reviews as a primary source of evidence in developing countries 2014 Hyderabad
• Barriers of best evidence implementation for preventing peripheral intravenous infusion extravasation in NICU newborns based on the i-PARIHS framework 2024 Prague [Global Evidence Summit]
• Barriers to and facilitators of evidence utilisation in healthcare in low-income settings: A qualitative systematic review 2017 Cape Town [Global Evidence Summit]
• Barriers to Cochrane Reviews of traditional medicine therapies: problems and potential solutions 2016 Seoul
• Barriers to implementation of evidence synthesis methods education for broad audiences 2018 Edinburgh
• Barriers to implementing evidence-based nursing practice from the hospitals' point of view in China: A regional cross-sectional study 2024 Prague [Global Evidence Summit]
• Barriers to knowledge translation in Chinese doctors: a cross-sectional survey 2013 Québec City
• Barriers to meta-analysis of time-to-event data: a case study 2006 Dublin
• Barriers to participating in an HIV vaccine trial: a systematic review of qualitative studies 2004 Ottawa
• Barriers to successful patient and public involvement on guideline panels and strategies to overcome them 2017 Cape Town [Global Evidence Summit]
• Baseline heterogeneity: a method to identify trials with bias arising from randomisation in meta-analyses 2020 Abstracts
• Basics of meta-analysis 2006 Dublin
• Basics of meta-analysis 2005 Melbourne
• Basics of meta-analysis 2008 Freiburg
• Bayesian approach to meta-analysis. What can you gain? 2011 Madrid
• Bayesian approaches to meta-epidemiology 2004 Ottawa
• Bayesian hierarchical models for complex meta-analyses using MCMCglmm in R 2012 Auckland
• Bayesian meta-analysis for quantifying treatment benefit of intravenous immunoglobulin (IVIG) in neonates 2004 Ottawa
• Bayesian meta-analysis hands-on in WinBUGS 2015 Vienna
• Bayesian methodological approaches used in the design of contemporary randomized clinical trials: protocol for a systematic review 2024 Prague [Global Evidence Summit]
• Bayesian mixed treatment comparison meta-analysis of interventions for Metabolic Syndrome 2008 Freiburg
• Be Smart about Your Health - Helping secondary school students think critically about health choices: Results of 3 randomized trials 2024 Prague [Global Evidence Summit]
• Beading plot: a visualization for summarizing outcomes among treatments of network meta-analysis 2024 Prague [Global Evidence Summit]
• Becoming a systematic review editor or peer reviewer for journals 2016 Seoul
• Becoming a systematic review editor or peer reviewer for journals 2017 Cape Town [Global Evidence Summit]
• Bed rest after subarachnoidal puncture to prevent headache: a systematic review 2000 Cape Town
• Bed Rest after Uncomplicated Acute Myocardial Infarction: Is it Any Good? A Systematic Review 2002 Stavanger
• Begin here! A non-scientist’s guide to Evidence-Based Medicine, Cochrane and getting involved 2018 Edinburgh
• Behavior change in Water, Sanitation and Hygiene (WASH) promotion programs: a review of reviews to identify evidence gaps 2016 Seoul
• Behavioral medicine: providing another perspective of trial methodologies 2005 Melbourne
• Behavioural therapy for chronic low back pain: how to interpret meta-analyses combining studies with multiple effect sizes? 1999 Rome
• Behind the dementia headlines. A systematic look at the quality of reporting of dementia research in two UK national newspapers 2011 Madrid
• Benefit-harm assessment: evidence selection 2016 Seoul
• Benefits and barriers in the development of a Rare Diseases Guidelines Programme in Europe 2024 Prague [Global Evidence Summit]
• Best evidence for better practice: using social media to help nurses engage with evidence 2015 Vienna
• Best evidence for optimal aging: filter the information overload using the McMaster Optimal Aging Portal 2015 Vienna
• Best evidence summary for smoking cessation management in patients with coronary heart disease 2024 Prague [Global Evidence Summit]
• Best practice in editorial and organisational processes of Collaborative Review Groups (on behalf of QAG) 2004 Ottawa
• Best practice in editorial policies, process, and publication 2018 Edinburgh
• Best practices in patient and stakeholder engagement 2012 Auckland
• Best-practice recommendations for using clinical trial registry records and published study protocols when conducting systematic reviews of interventions 2017 Cape Town [Global Evidence Summit]
• Best-practice statements in public-health guidelines 2017 Cape Town [Global Evidence Summit]
• Beta-test of a software program designed to facilitate systematic research reviews 1998 Baltimore
• Betahistine for vertigo: a patient-professional partnership in action 2015 Vienna
• Better data extraction with Covidence and RevMan Web 2023 London
• Better dissemination using Cochrane's Dissemination Checklist: Cochrane UK's experience 2020 Abstracts
• Better reporting of health equity in randomised trials: CONSORT-Equity 2017 2017 Cape Town [Global Evidence Summit]
• Better values clarification methods for better decisions 2013 Québec City
• Better, faster, stronger: how to find tools to expedite the systematic review process 2018 Edinburgh
• Between-the-eyes adverse drug reactions: anecdotes as evidential gold standards 2006 Dublin
• Beyond Clinical Effectiveness - the Role of the UK NHS Economic Evaluation Database in Providing Best Evidence for Health Care 1999 Rome
• Beyond publication bias 2010 Keystone
• Beyond Statistical Significance: Investigating How Systematic Review Authors Communicate Meaningful Differences of Nonsignificant Results 2023 London
• Beyond synthesis: developing a research program on knowledge translation and exchange 2008 Freiburg
• Beyond Systematic Reviews: Other Possible Activities for the Cochrane Centres 2002 Stavanger
• Beyond the pandemic: adapting living guideline methods from COVID-19 to the Australian Pregnancy and Postnatal Care Guidelines 2024 Prague [Global Evidence Summit]
• Beyond the RCT: how global patient organisations build research capacity and impact 2018 Edinburgh
• Beyond the surface: navigating the maze of evidence definitions across disciplines 2024 Prague [Global Evidence Summit]
• Beyond the systematic review: an example of a pilot decision analysis 1998 Baltimore
• Beyond theories: advancing development evaluation frameworks 2024 Prague [Global Evidence Summit]
• Bias adjustment in meta-analysis using expert opinions 2023 London
• Bias associated with inadequate or unclear concealment of allocation in randomized osteoarthritis trials 2008 Freiburg
• Bias associated with patient reported outcome measures 2018 Edinburgh
• Bias associated with selective crossover in randomised controlled trials 2012 Auckland
• Bias in case-control studies of screening effects 1995 Oslo
• Bias in measurement of adverse outcomes in non-randomised studies 2015 Vienna
• Bias In Meta-Analysis Due To Within Study Selective Reporting 1999 Rome
• Bias in meta-epidemiological studies: an exchange of ideas 2018 Edinburgh
• Bias in surgical randomised trials: a meta-epidemiological study using laparoscopic versus open surgery as an example 2018 Edinburgh
• Bias-adjusted meta-analysis: a workshop for researchers 2024 Prague [Global Evidence Summit]
• Bibliographic analysis of the Cochrane Effective Practice and Organisation of Care Group's reviews 2006 Dublin
• Bibliometric analyses along cumulative meta-analyses: the Life Cycle of Evidence in Cancer Care (LIFE CYCLE) 2005 Melbourne
• Bibliometric analysis of ‘overviews of systematic reviews’ from 2000 to 2018 2020 Abstracts
• Bibliometric analysis of 100 most cited Cochrane Systematic Reviews 2011 Madrid
• Bibliometric Analysis of ChatGPT’s Application in the Medical Field 2024 Prague [Global Evidence Summit]
• Big vs. Small data: Opportunities in new data sources for evidence generation 2017 Cape Town [Global Evidence Summit]
• BINDING SCIENCE AND SOCIETY: ANALYZING THE INFLUENCE OF SOCIOECONOMIC FACTORS ON GLOBAL SCIENTIFIC OUTPUT 2024 Prague [Global Evidence Summit]
• Biomedical databases: selection and searching for trials to conduct systematic reviews for Chinese reviewers 2015 Vienna
• Bispectral index for improving anaesthetic delivery and postoperative recovery 2004 Ottawa
• Bivariate meta-analysis of predictive values 2010 Keystone
• Bivariate meta-analysis of sensitivity and specificity in diagnostic reviews 2005 Melbourne
• Bivariate network meta-analysis of diagnostic test accuracy studies synthesising multiple tests and multiple thresholds 2017 Cape Town [Global Evidence Summit]
• Bladder management in postpartum women after vaginal or caesarean delivery: a best practice implementation project 2024 Prague [Global Evidence Summit]
• Blinded assessment of the methodological quality 1997 Amsterdam
• Blinding in randomised controlled trials of surgical procedures in children: who, when and how 2012 Auckland
• Blood Calprotectin Quantitative High-quality Immunoassay: systematic review 2024 Prague [Global Evidence Summit]
• Blood pressure increasing effect of sibutramine in obese patients 2004 Ottawa
• Blood pressure variability; lessons learned from a systematic review 2000 Cape Town
• Blood Pressure-Lowering Efficacy: A Family of Systematic Reviews of Different Classes of Antihypertensive Drugs 2002 Stavanger
• Blood transfusions for treating acute chest syndrome in people with sickle cell disease 2020 Abstracts
• Blood-donor eligibility in Belgian Red Cross’ Blood Service: from systematic reviews to impact on policy level 2017 Cape Town [Global Evidence Summit]
• Bloodletting therapy for primary headache: A systematic review and meta-analysis of randomized controlled trials 2024 Prague [Global Evidence Summit]
• Boosting global and local partnerships to promote equitable access of COVID-19 guideline recommendations: case study in China 2023 London
• Bradford’s law to predict the size of the literature in cochrane reviews 2010 Keystone
• Brain metastasis management: difficulties with integrating Cochrane Review evidence into guidelines 2013 Québec City
• Brazil’s growing production of scientific review articles 2013 Québec City
• Brazilian Cochrane as MD, PhD program training center 2019 Santiago
• Brazilian Cochrane Center strategies for disseminating the Cochrane methodology for systematic reviews 2013 Québec City
• Brazilian evidence support system for equitable health policies: pub crawl around the Brazilian Coalition for Evidence 2024 Prague [Global Evidence Summit]
• Brazilian guideline for diagnosis and treatment of Chagas disease 2017 Cape Town [Global Evidence Summit]
• Brazilian guideline for lung cancer: recommendations and development process 2024 Prague [Global Evidence Summit]
• Brazilian guidelines for the management of adult potential brain-dead donors 2017 Cape Town [Global Evidence Summit]
• Brazilian national guideline for Alzheimer’s disease: recommendations and development process 2024 Prague [Global Evidence Summit]
• Brazilian national guideline for sickle cell disease: recommendations and development process 2024 Prague [Global Evidence Summit]
• Brazilian national guideline for systemic arterial hypertension: recommendations and development process 2024 Prague [Global Evidence Summit]
• Brazilian oral health journals in Scielo: an open access tropical treasure? 2008 Freiburg
• Brazilian private health insurance guidelines: implementing coverage criteria 2024 Prague [Global Evidence Summit]
• Brazilian Spinal Muscular Atrophy Clinical Practice Guidelines History 2024 Prague [Global Evidence Summit]
• Brazilian Transcultural Adaptation of Informative Statements to Communicate the Findings of Systematic Reviews of Interventions indicated by the GRADE System 2024 Prague [Global Evidence Summit]
• Breadth and depth of review questions: mixed methods, mapping, reviews of reviews and other methods for enabling analysis of broad questions and heterogeneous data 2010 Keystone
• Breaking barriers in guideline implementation: introducing a novel software approach for standardizing clinical pathways 2024 Prague [Global Evidence Summit]
• Breaking Ground or Breaking Bad? Examining the Fate of Preprints in Prevention Research with a Mixed Methods Study 2023 London
• Breaking silos, building bridges: leveraging collaborative evidence networks for global impact 2024 Prague [Global Evidence Summit]
• Breakthroughs and challenges in conducting systematic reviews on rare diseases: implications of the ERNs Guidelines Programme 2024 Prague [Global Evidence Summit]
• Breast cancer screening: effective and efficient as well as efficacious 1997 Amsterdam
• Breast cancer screening: effective and efficient as well as efficacious 1997 Amsterdam
• Breastfeeding on health: a Living Overview of the Evidence (L-OVE) 2019 Santiago
• Breastfeeding support and avoiding inappropriate breastmilk substitutes marketing in a neonatal ward in the Czech Republic 2023 London
• Bridging clinical investigators and statisticians: publication status and problems of Statistical Analysis Plan (SAP) 2016 Seoul
• Bridging evidence and policy: insights from conflict and atrocity prevention Evidence and Gap Map 2024 Prague [Global Evidence Summit]
• Bridging evidence and practice: interprofessional nursing and pharmacy student training in navigating NICE resources 2024 Prague [Global Evidence Summit]
• Bridging evidence and practice: the experience of GESI Network members in engaging stakeholders 2019 Santiago
• Bridging gaps between Chinese reviewers and Cochrane review groups 2004 Ottawa
• Bridging Gaps in Health Professional In-service Education: Harnessing Technology to improve accessibility and monitoring in Primary Care Training 2024 Prague [Global Evidence Summit]
• Bridging Gaps, Empowering Tomorrow’s Leaders: Lessons Learned from the 2021-2023 Cochrane US Global Health Equity Mentoring Program 2024 Prague [Global Evidence Summit]
• Bridging the gap between research results and decision making in clinical practice: common problems in the development and use of a national Electronic Library of Health Care 2004 Ottawa
• Bridging the gap between science and policy at the agri-food and public health interface through a knowledge synthesis, transfer and exchange handbook 2013 Québec City
• Bridging the gap from research to practice: the emergence of a community of practice in EBM at the department of family medicine at Laval university 2004 Ottawa
• Bridging the Gap: Empowering LMICs through Cochrane Evidence: Experiences of Cochrane Centers in Low- and Middle-Income Countries 2024 Prague [Global Evidence Summit]
• Bridging the gaps across the income divide: A review of The Collaboration's efforts to date and recommendations for the future 2004 Ottawa
• Bridging the gaps between evidence-based and experience-based medicine in a Swiss Cochrane Symposium 2004 Ottawa
• Bridging the gaps between prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling 2004 Ottawa
• Bridging the information gap in Saskatchewan: Accessing and using The Cochrane Library province-wide 2004 Ottawa
• Bringing a patient perspective to understanding interventions that aim to reduce length of stay in hospital: a mixed methods synthesis 2023 London
• Bringing a systematic element to complex focussed literature reviews 2018 Edinburgh
• Bringing best evidence to front line clinicians 2011 Madrid
• Bringing Cochrane reviews to Polish professionals and consumers 2023 London
• Bringing diabetes "Alive": a radical new approach to collaborative living evidence 2024 Prague [Global Evidence Summit]
• Bringing evidence into practice: Use of a rapid review methodology to formulate medical recommendations for the Red Cross Blood Service 2011 Madrid
• Bringing GRADEpro to Health Technology Assessment: a pilot study to improve quality and transparency of Scoping and Project Plan in EUnetHTA 2018 Edinburgh
• Bringing Narrative Evidence 'into the Fold': Methods for Generalizing from Individual Narrative Data 1999 Rome
• Bringing policy makers closer to systematic reviews: Brazilian strategies 2010 Keystone
• Bringing the culture of Cochrane to a professional medical association 2010 Keystone
• Bringing them to the table: a clarion call for considerations of digital accessibility of evidence resources to PWDs 2024 Prague [Global Evidence Summit]
• Broad versus narrow questions: empirical evidence of lumping and splitting of topics in Cochrane Perinatal Reviews 2000 Cape Town
• Budget impact analysis in the Brazilian supplementary health care: developing an optimal spreadsheet 2024 Prague [Global Evidence Summit]
• Budget impact of including short-acting insulin analogues in the public-health system of an upper-middle income country 2017 Cape Town [Global Evidence Summit]
• Building "TULAY" (bridges) through codesigning a self-management support for stroke survivors in the Philippines 2024 Prague [Global Evidence Summit]
• Building a clean and comprehensive study-based register of reports of diagnostic test accuracy studies 2007 Sao Paulo
• Building a Crowd community of 'citizen scientists' in the US through engagement and strategic partnerships 2018 Edinburgh
• Building a database of respiratory guidelines: why, how, and what for? 2015 Vienna
• Building a database of systematic reviews about patient safety: providing clinicians with easier access to evidence 2009 Singapore
• Building a database of validated pediatric outcomes 2011 Madrid
• Building a database of validated pediatric outcomes: an investigation of compliance with established reporting standards 2013 Québec City
• Building a diverse community: new ways to participate in Cochrane 2019 Santiago
• Building a nationwide online platform for evidence-based information in primary healthcare in Belgium 2017 Cape Town [Global Evidence Summit]
• Building a network within the evidence community: the Evidence-Based Research Network (EBRNetwork) 2024 Prague [Global Evidence Summit]
• Building a research team: A Cochrane US Network experience focusing on racial health equity 2023 London
• Building a shared global evidence database to facilitate evidence-based decision-making in education 2024 Prague [Global Evidence Summit]
• Building a specialized register of behavioral medicine interventions 2005 Melbourne
• Building a systematic review movement in the humanitarian field 2015 Vienna
• Building a truly global evidence ecosystem: achieving impactful collaboration by embracing equity, diversity, and inclusion 2024 Prague [Global Evidence Summit]
• Building acceptance for machine learning in study selection within a systematic review institution: Experiences from the Norwegian Institute of Public Health 2023 London
• Building actionable knowledge from referential knowledge for evidence-based nursing practice 2015 Vienna
• Building an effective forum for evidence-informed climate change solutions 2024 Prague [Global Evidence Summit]
• Building an organization-wide evidence synthesis support system at the Public Health Agency of Canada 2024 Prague [Global Evidence Summit]
• Building awareness for evidence-based practice in Malaysia 2017 Cape Town [Global Evidence Summit]
• Building bridges between systematic reviews and Brazilian decision-making: methods for disseminating evidence 2007 Sao Paulo
• Building Bridges: A Blueprint for establishing a Synthesis Research Center in Turkey 2024 Prague [Global Evidence Summit]
• Building capacity for Cochrane activity in South East Asia: impact of the SEA-ORCHID Project 2009 Singapore
• Building capacity for systematic reviews in low-income countries beyond the classroom: the Africa centre for systematic reviews and knowledge translation 2015 Vienna
• Building capacity for systematic reviews in low-income countries: the Africa centre for systematic reviews and knowledge translation 2014 Hyderabad
• Building capacity in EBHC: What is happening in the African region? 2011 Madrid
• Building capacity in producing trusted evidence – Evidence Synthesis Ireland and Cochrane Ireland Fellowships 2023 London
• Building Capacity of Indian Scientists in Conduct of Systematic Reviews: an Indian Council of Medical Research (ICMR) Initiative 2013 Québec City
• Building capacity to support evidence-informed public health: an innovative knowledge broker mentoring program 2015 Vienna
• Building capacity to understand and communicate complex science 2024 Prague [Global Evidence Summit]
• Building capacity with Cochrane webinars: tips and tricks for presenters 2012 Auckland
• Building evidence utilisation capacity of health policy makers at the Federal Ministry of Health in Ethiopian: Mentor – mentee experience 2017 Cape Town [Global Evidence Summit]
• Building evidence-based public health capacity in Africa: developing and piloting a workshop 2019 Santiago
• Building more robust search strategies in Cochrane systematic reviews: towards improving inter-information specialists’ agreement 2019 Santiago